A new compound removes senescent cells and reduces toxicity in cancer treatment

Researchers at CIBER-BBN, the Universitat Politècnica de València, the Principe Felipe Research Center and the University of Cambridge confirm the therapeutic potential of using a new conjugated drug, Nav-Gal, in combination with chemotherapy.